Prognostic Value of Coronary CT Angiography-derived Fractional Flow Reserve on 3-year Outcomes in Patients with

Kristian T Madsen1, Bjarne L Nørgaard1, Kristian A Øvrehus1

  • 1From the Department of Cardiology, University Hospital of Southern Denmark, Esbjerg, Finsensgade 35, Esbjerg DK-6700, Denmark (K.T.M., A.R., N.P.R.S.); Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (B.L.N., J.M.J., E.L.G., H.E.B.); Department of Clinical Medicine, Faculty of Health (B.L.N., E.L.G.), and Department of Public Health, Section for Biostatistics (E.P.), Aarhus University, Aarhus, Denmark; Department of Cardiology, Odense University Hospital, Odense, Denmark (K.A.Ø., H.M.); Department of Cardiology, Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom (T.A.F.); Departments of Cardiovascular Medicine and Radiology, Stanford University, Stanford, Calif (K.N.); Division of Cardiology, Department of Medicine, Duke University, Durham, NC (M.R.P.); HeartFlow Inc, Mountain View, Calif (C.R., S.M.); Department of Radiology, Providence Health Care, St. Paul's Hospital, University of British Columbia, Vancouver, Canada (J.L.); and Department of Regional Health Research, University of Southern Denmark, Esbjerg, Denmark (N.P.R.S.).

Radiology
|September 12, 2023
PubMed

Insights

A normal coronary computed tomography angiography (CTA)-derived fractional flow reserve (FFR) test reliably predicts a low 3-year risk of death or heart attack in stable angina patients, including those with high coronary artery calcium (CAC).

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Diagnostic Accuracy

Background:

  • The prognostic significance of coronary computed tomography angiography (CTA)-derived fractional flow reserve (FFR) beyond one year, particularly in patients with high coronary artery calcium (CAC), remains unclear.
  • Accurate risk stratification is crucial for managing patients with coronary stenosis and stable angina pectoris.

Purpose of the Study:

  • To evaluate the 3-year prognostic value of coronary CTA-derived FFR results for clinical outcomes in patients with coronary stenosis.
  • To specifically assess this prognostic value in a subgroup of patients characterized by high levels of CAC.

Main Methods:

  • A 3-year follow-up of 900 patients with stable angina enrolled in the ADVANCE registry (ClinicalTrials.gov: NCT02499679).
  • Coronary CTA-derived FFR was assessed, with abnormal results defined as a value ≤0.80.
  • High CAC was defined as an Agatston score ≥400. The primary endpoint was a composite of all-cause death and nonfatal spontaneous myocardial infarction.

Main Results:

  • The primary endpoint occurred in 2.1% of patients with normal CTA-derived FFR versus 6.6% with abnormal results (Relative Risk [RR] 3.1; P < .001).
  • In the high CAC subgroup, the primary endpoint occurred in 2.2% with normal CTA-derived FFR versus 9.0% with abnormal results (RR 4.1; P = .001).
  • A normal CTA-derived FFR result was associated with significantly lower rates of the primary endpoint in both the overall cohort and the high CAC subgroup.

Conclusions:

  • In patients with stable angina, a normal coronary CTA-derived FFR result effectively identifies individuals at low risk for 3-year adverse cardiovascular events (death or myocardial infarction).
  • This finding holds true for the general cohort and specifically for patients with high CAC scores, supporting its utility in risk stratification.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
39
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
41